Table 1.
Type of Patients | |||
---|---|---|---|
No xerostomia (i: N = 82) | Injury and Recovery (ii: N = 135) | Injury but No recovery (iii: N = 41) | |
Age >65 years * | 26 (31.7) | 35 (25.9) | 11 (26.8) |
Race * | |||
Caucasian | 61 (75) | 109 (78) | 36 (83) |
African American | 19 (23) | 23 (17) | 4 (10) |
Other | 2 (2) | 3 (2) | 1 (2) |
Gender * | |||
Female | 24 (29) | 21 (16) | 11 (27) |
Male | 58 (71) | 114 (84) | 30 (73) |
Tumor site * | |||
Hypopharynx | 2 (2) | 2 (1) | 2 (5) |
Larynx | 15 (18) | 20 (15) | 0 (0) |
Nasopharynx | 3 (4) | 7 (5) | 0 (0) |
Oral Cavity | 11 (13) | 43 (32) | 12 (29) |
Oropharynx | 27 (33) | 51 (38) | 22 (54) |
Others | 24 (29) | 12 (9) | 5 (12) |
T stage ** | |||
0 and 1 | 25 (30) | 38 (28) | 5 (12) |
2 and above | 43 (52) | 88 (65) | 30 (73) |
missing | 14 (17) | 9 (7) | 6 (14) |
N stage ** | |||
0 | 31 (38) | 36 (27) | 8 (20) |
1 and 2 | 37 (45) | 88 (65) | 26 (63) |
missing | 14 (17) | 11 (8) | 7 (17) |
M stage** | |||
M0 | 63 (77) | 121 (90) | 33 (80) |
M1 | 1 (1) | 2 (1) | 3 (7) |
missing | 18 (22) | 12 (9) | 5 (12) |
Chemotherapy* | |||
Yes | 49 (60) | 99 (73) | 27 (66) |
No | 33 (40) | 36 (27) | 14 (34) |
Volume – cc *** (mean ± sd) | |||
iPG | 57.9 ± 18.6 | 60.4 ± 18.6 | 53.6 ± 18.7 |
cPG | 58.6 ± 17.8 | 60.7 ± 18.6 | 54.6 ± 17.5 |
iSMG | 19.9 ± 7.2 | 21.3 ± 11.2 | 18.7 ± 5.4 |
cSMG | 21.0 ± 6.1 | 21.5 ± 11.3 | 18.9 ± 5.2 |
iOC | 178.1 ± 42.7 | 180.3 ± 40.01 | 177.1 ± 38.9 |
cOC | 176.6 ± 41.7 | 178.9 ± 40.1 | 177.2 ± 40.0 |
*Categorical variables were displayed as count and percentage.
**American Joint Committee on Cancer (AJCC) staging 7.0th edition. For T stage, 0 includes T0 and Tis; 4 includes T4a and T4b. For N stage, 2 includes N2a, N2b and N2c.
***Continuous variables were displayed as mean ± SD. Volume includes contours +3 mm shell.